中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

乙型肝炎相关慢加急性肝衰竭患者预后的危险因素分析

石新星 张艳琼 朱鹏 闫国华 张长江 王宇明

引用本文:
Citation:

乙型肝炎相关慢加急性肝衰竭患者预后的危险因素分析

DOI: 10.3969/j.issn.1001-5256.2016.04.018
基金项目: 

国家“十二五”科技重大专项(2012ZX10002004); 国家自然科学基金面上项目(81270536); 

详细信息
  • 中图分类号: R575.3;R512.62

Prognostic risk factors in patients with hepatitis B virus- related acute- on- chronic liver failure

Research funding: 

 

  • 摘要:

    目的探讨乙型肝炎相关慢加急性肝衰竭(HBV-ACLF)患者的临床特征及远期预后的危险因素。方法回顾性分析第三军医大学西南医院2010年1月-2015年1月住院的1116例HBV-ACLF患者的临床资料,观察影响患者1年生存时间及预后的危险因素,通过Cox回归模型筛选出影响预后的独立危险因素。计量资料组间比较采用t检验或t’检验,计数资料组间比较采用χ2检验。结果在随访的1年时间内,562例患者死亡,病死率为50.4%。生存组和死亡组比较:年龄、ALT、TBil、尿素氮、血肌酐、国际标准化比值、血清Na+、白细胞(WBC)、中性粒细胞百分比、血小板(PLT)、HBV DNA载量、MELD评分、腹水、自发性细菌性腹膜炎、消化道出血、肺部感染、脓毒症、电解质紊乱、肝性脑病及急性肾损伤(AKI)在2组间的差异均有统计学意义(P值均<0.05)。Cox回归分析结果显示:年龄、WBC、MELD评分、肝性脑病、电解质紊乱、AKI及PLT是HBV-ACLF患者1年病死率的独立危险因素(P值均<0.05)。结论 HBV-ACLF是一个高病死率疾病,...

     

  • [1]BROCHARD L,ABROUG F,BRENNER M,et al.An official ATS/ERS/ESICM/SCCM/SRLF statement:prevention and management of acute renal failure in the ICU patient:an international consensus conference in intensive care medicine[J].Am J Respir Crit Care Med,2010,181(10):1128-1155.
    [2]JALAN R,GINES P,OLSON JC,et al.Acute-on chronic liver failure[J].J Hepatol,2012,57(6):1336-1348.
    [3]OLSON JC,KAMATH PS.Acute-on-chronic liver failure:concept,natural history,and prognosis[J].Curr Opin Crit Care,2011,17(2):165-169.
    [4]SARIN SK,KEDARISETTY CK,ABBAS Z,et al.Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL)2014[J].Hepatol Int,2014,8(4):453-471.
    [5]LIU C,WANG YM,FAN K.Epidemiological and clinical features of hepatitis B virus related liver failure in China[J].World J Gastroenterol,2011,17(25):3054-3059.
    [6]YOU S,RONG Y,ZHU B,et al.Changing etiology of liver failure in 3,916 patients from northern China:a 10-year survey[J].Hepatol Int,2013,7(2):714-720.
    [7]MOREAU R,JALAN R,GINES P,et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J].Gastroenterology,2013,144(7):1426-1437,1437.e1-e9.
    [8]FU SJ,GAO GS,HU AR,et al.Short-term prognostic value of serum procalctonin and common inflammation markers combined with CTP score in patients with acute-on-chronic liver failure[J].Chin J Pract Intern Med,2015,35(6):519-521.(in Chinese)傅叁君,高国生,胡爱荣,等.血清降钙素原和常用炎症指标联合CTP评分对慢加急性肝衰竭短期预后的预测价值[J].中国实用内科杂志,2015,35(6):519-521.
    [9] Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association;Severe Liver Diseases and Artificial Liver Group,Chinese Society of Hepatology,Chinese Medical Association.Guidelines for diagnosis and treatment liver failure[J].Chin J Clin Infect Dis,2012,5(6):321-327.(in Chinese)中华医学会感染学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版)[J].中华临床感染病杂志,2012,5(6):321-327.
    [10]PALEVSKY PM,LIU KD,BROPHY PD,et al.KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury[J].Am J Kidney Dis,2013,61(5):649-672.
    [11]European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis[J].J Hepatol,2010,53(3):397-417.
    [12]MOREAU R,ARROYO V.Acute-on-chronic liver failure:a new clinical entity[J].Clin Gastroenterol Hepatol,2015,13(5):836-841.
    [13]LIU XY,XIN SJ.Significance of liver failure staging in predicting the prognosis of HBV-acute-on-chronic liver failure[J].Acade J Chin PLA Med Sch,2014,35(6):521-524.(in Chinese)刘晓燕,辛绍杰.肝衰竭分期对HBV感染慢加急性肝衰竭预后判断的意义[J].解放军医学院学报,2014,35(6):521-524.
    [14]XIA Q,DAI X,ZHANG Y,et al.A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients[J].PLoS One,2013,8(6):e64379.
    [15]SHI Y,ZHENG MH,YANG Y,et al.Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation[J].J Gastroenterol Hepatol,2015,30(4):712-718.
    [16]MALIK R,MOOKERJEE RP,JALAN R.Infection and inflammation in liver failure:two sides of the same coin[J].J Hepatol,2009,51(3):426-429.
    [17]CORDOBA J,VENTURA-COTS M,SIMON-TALERO M,et al.Characteristics,risk factors,and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure(ACLF)[J].J Hepatol,2014,60(2):275-281.
    [18]FICHET J,MERCIER E,GENEE O,et al.Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy[J].J Crit Care,2009,24(3):364-370.
    [19]SHAWCROSS DL,DAVIES NA,WILLIAMS R,et al.Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis[J].J Hepatol,2004,40(2):247-254.
    [20]JOSHI D,O'GRADY J,PATEL A,et al.Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with highgrade hepatic encephalopathy[J].Liver Int,2014,34(3):362-366.
  • 加载中
计量
  • 文章访问数:  2529
  • HTML全文浏览量:  11
  • PDF下载量:  450
  • 被引次数: 0
出版历程
  • 出版日期:  2016-04-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回